Our findings demonstrated that UBA7 downregulation in SF3B1-mutant CLL is strongly linked to poor survival, suggesting its potential integration into prognostic models to enhance the prediction of disease progression. Here, UBA7 is linked to B-cell chronic lymphocytic leukemia.